HPC has developed into a well-known consulting company in the pharmaceutical industry on the East Coast of the United States. It is also a pioneering team specializing in international pharmaceutical development and registration and business consulting across China and the United States. The company not only provides customers with technical support and regulatory consulting services related to FDA registration and development, but also provides customers with business consulting services related to the industrialization of pharmaceutical products, market development, investment and financing, and project transfer/M&A. The company’s clients include various pharmaceutical manufacturers, medical device companies, and financial investment institutions from the United States, Europe, Japan, and other Asian countries and regions. HPC has served more than 50 pharmaceutical companies in China and enabled their products to enter the U.S. and Canadian markets. HPC is striving to open more doors for Chinese pharmaceutical professionals. HPC is willing to work with all Chinese pharmaceutical professionals to seize opportunities, face challenges, and finally realize the dream of modernizing the Chinese pharmaceutical industry.
